Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical Orthopaedics and Related Research®
Published in: Clinical Orthopaedics and Related Research® 10/2013

01-10-2013 | Clinical Research

Long-term (20- to 25-year) Results of an Uncemented Tapered Titanium Femoral Component and Factors Affecting Survivorship

Authors: Marcus R. Streit, MD, MSc, Moritz M. Innmann, MD, Christian Merle, MD, MSc, Thomas Bruckner, PhD, Peter R. Aldinger, MD, PhD, Tobias Gotterbarm, MD

Published in: Clinical Orthopaedics and Related Research® | Issue 10/2013

Login to get access

Abstract

Background

Uncemented femoral components in primary total hip arthroplasty (THA) are commonly used today, but few studies have evaluated their survival into the third decade.

Questions/purposes

We evaluated (1) survivorship using femoral revision for any reason as the end point; (2) survivorship using femoral revision for aseptic loosening as the end point; and (3) patient-related and surgical risk factors for aseptic stem loosening at a minimum 20-year followup with an uncemented tapered titanium stem.

Methods

We reviewed the clinical and radiographic results of 354 THAs in 326 patients performed between January 1985 and December 1989 using an uncemented grit-blasted, tapered titanium femoral stem. Mean age at surgery was 57 years (range, 13–81 years). Kaplan-Meier survivorship analysis was used to estimate long-term survival. Minimum followup evaluation was 20 years (mean, 22 years; range, 20–25 years); at that time, 120 patients (127 hips) had died, and four patients (five hips) were lost to followup. Multivariate survival analysis using a Cox regression model was performed.

Results

Survivorship at 22 years with revision of the femoral component for any reason as the end point was 86% (95% confidence interval [CI], 81%–90%). Survivorship for femoral revision for aseptic loosening as the end point was 93% at 22 years (95% CI, 90%–96%). Undersized stems (canal fill index ≤ 80%) and stems in hips with cup revision were at higher risk for aseptic loosening (hazard ratio, 4.2 and 4.3, respectively). There was a high rate of acetabular revision in this series (38%), mostly related to smooth-threaded, cementless sockets.

Conclusions

Uncemented femoral fixation was reliable into the third decade. Age, male sex, and diagnosis were not associated with a higher risk of aseptic loosening.

Level of Evidence

Level IV, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence.
Literature
1.
Al Muderis M, Bohling U, Grittner U, Gerdesmeyer L, Scholz J. Cementless total hip arthroplasty using the Spongiosa-I fully coated cancellous metal surface: a minimum twenty-year follow-up. J Bone Joint Surg Am. 2011;93:1039–1044.PubMedCrossRef
2.
Aldinger PR, Breusch SJ, Lukoschek M, Mau H, Ewerbeck V, Thomsen M. A ten- to 15-year follow-up of the cementless spotorno stem. J Bone Joint Surg Br. 2003;85:209–214.PubMedCrossRef
3.
Aldinger PR, Jung AW, Breusch SJ, Ewerbeck V, Parsch D. Survival of the cementless Spotorno stem in the second decade. Clin Orthop Relat Res. 2009;467:2297–2304.PubMedCrossRef
4.
Bauer R, Kerschbaumer F, Poisel S, Oberthaler W. The transgluteal approach to the hip joint. Arch Orthop Trauma Surg. 1979;95:47–49.PubMedCrossRef
5.
Belmont PJ Jr, Powers CC, Beykirch SE, Hopper RH Jr, Engh CA Jr, Engh CA. Results of the anatomic medullary locking total hip arthroplasty at a minimum of twenty years. A concise follow-up of previous reports. J Bone Joint Surg Am. 2008;90:1524–1530.PubMedCrossRef
6.
Berry DJ, Harmsen WS, Cabanela ME, Morrey BF. Twenty-five-year survivorship of two thousand consecutive primary Charnley total hip replacements: factors affecting survivorship of acetabular and femoral components. J Bone Joint Surg Am. 2002;84:171–177.PubMed
7.
Biemond JE, Pakvis DF, van Hellemondt GG, Buma P. Long-term survivorship analysis of the cementless Spotorno femoral component in patients less than 50 years of age. J Arthroplasty. 2011;26:386–390.PubMedCrossRef
8.
Bourne RB, Corten K. Cemented versus cementless stems: a verdict is in. Orthopedics. 2010;33:638.PubMed
9.
Brooker AF, Bowerman JW, Robinson RA, Riley LH Jr. Ectopic ossification following total hip replacement. Incidence and a method of classification. J Bone Joint Surg Am. 1973;55:1629–1632.PubMed
10.
Callaghan JJ, Templeton JE, Liu SS, Pedersen DR, Goetz DD, Sullivan PM, Johnston RC. Results of Charnley total hip arthroplasty at a minimum of thirty years. A concise follow-up of a previous report. J Bone Joint Surg Am. 2004;86:690–695.PubMed
11.
Clohisy JC, Harris WH. The Harris-Galante uncemented femoral component in primary total hip replacement at 10 years. J Arthroplasty. 1999;14:915–917.PubMedCrossRef
12.
Cook RE, Jenkins PJ, Walmsley PJ, Patton JT, Robinson CM. Risk factors for periprosthetic fractures of the hip: a survivorship analysis. Clin Orthop Relat Res. 2008;466:1652–1656.PubMedCrossRef
13.
Corten K, Bourne RB, Charron KD, Au K, Rorabeck CH. What works best, a cemented or cementless primary total hip arthroplasty? Minimum 17-year followup of a randomized controlled trial. Clin Orthop Relat Res. 2011;469:209–217.PubMedCrossRef
14.
de Witte PB, Brand R, Vermeer HG, van der Heide HJ, Barnaart AF. Mid-term results of total hip arthroplasty with the CementLess Spotorno (CLS) system. J Bone Joint Surg Am. 2011;93:1249–1255.PubMedCrossRef
15.
Devane PA, Horne JG, Martin K, Coldham G, Krause B. Three-dimensional polyethylene wear of a press-fit titanium prosthesis. Factors influencing generation of polyethylene debris. J Arthroplasty. 1997;12:256–266.PubMedCrossRef
16.
17.
Engh CA, Bobyn JD, Glassman AH. Porous-coated hip replacement. The factors governing bone ingrowth, stress shielding, and clinical results. J Bone Joint Surg Br. 1987;69:45–55.PubMed
18.
Ferrell MS, Browne JA, Attarian DE, Cook C, Bolognesi MP. Cementless porous-coated anatomic total hip arthroplasty at Duke: 18- to 24-year follow-up. J Surg Orthop Adv. 2009;18:150–154.PubMed
19.
Garellick G, Kärrholm J, Rogmark C, Herberts P. Swedish Hip Arthroplasty Register Annual Report 2010. Gothenburg, Sweden: Swedish Hip Arthroplasty Register; 2011.
20.
Grappiolo G, Burastero G, Moraca G, Camera A, Santoro G, Gruen T, Spotorno L. The CLS stem in primary tha. long-term results and survivorship analysis of a tapered, grit-blasted, press-fit femoral prosthesis. J Bone Joint Surg Br. 2009;91:51.CrossRef
21.
Gruen TA, McNeice GM, Amstutz HC. ‘Modes of failure’ of cemented stem-type femoral components: a radiographic analysis of loosening. Clin Orthop Relat Res. 1979;141:17–27.PubMed
22.
Güther D, Pap G, Bamert P, Eggli S. [Long-term results with the cementless CLS stem in hip replacement] [in German]. Z Orthop Ihre Grenzgeb. 2003;141:309–315.PubMedCrossRef
23.
Haddad RJ Jr, Skalley TC, Cook SD, Brinker MR, Cheramie J, Meyer R, Missry J. Clinical and roentgenographic evaluation of noncemented porous-coated anatomic medullary locking (AML) and porous-coated anatomic (PCA) total hip arthroplasties. Clin Orthop Relat Res. 1990;258:176–182.PubMed
24.
Hailer NP, Garellick G, Karrholm J. Uncemented and cemented primary total hip arthroplasty in the Swedish Hip Arthroplasty Register. Acta Orthop. 2010;81:34–41.PubMedCrossRef
25.
Hallan G, Lie SA, Furnes O, Engesaeter LB, Vollset SE, Havelin LI. Medium- and long-term performance of 11,516 uncemented primary femoral stems from the Norwegian arthroplasty register. J Bone Joint Surg Br. 2007;89:1574–1580.PubMed
26.
Hardoon SL, Lewsey JD, Gregg PJ, Reeves BC, van der Meulen JH. Continuous monitoring of the performance of hip prostheses. J Bone Joint Surg Br. 2006;88:716–720.PubMed
27.
Harris WH. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Joint Surg Am. 1969;51:737–755.PubMed
28.
Hwang KT, Kim YH, Kim YS, Choi IY. Total hip arthroplasty using cementless grit-blasted femoral component: a minimum 10-year follow-up study. J Arthroplasty. 2012;27:1554–1561.PubMedCrossRef
29.
Jasty M, Maloney WJ, Bragdon CR, O’Connor DO, Haire T, Harris WH. The initiation of failure in cemented femoral components of hip arthroplasties. J Bone Joint Surg Br. 1991;73:551–558.PubMed
30.
Khanuja HS, Vakil JJ, Goddard MS, Mont MA. Cementless femoral fixation in total hip arthroplasty. J Bone Joint Surg Am. 2011;93:500–509.PubMedCrossRef
31.
Kim YH. Long-term results of the cementless porous-coated anatomic total hip prosthesis. J Bone Joint Surg Br. 2005;87:623–627.PubMed
32.
Kim YH, Kim JS, Park JW, Joo JH. Periacetabular osteolysis is the problem in contemporary total hip arthroplasty in young patients. J Arthroplasty. 2012;27:74–81.PubMedCrossRef
33.
Laine HJ, Pajamaki KJ, Moilanen T, Lehto MU. The femoral canal fill of two different cementless stem designs. The accuracy of radiographs compared to computed tomographic scanning. Int Orthop. 2001;25:209–213.PubMedCrossRef
34.
Ling R. The History and Development of the Exeter Hip. Rutherford, NJ, USA: Howmedica; 1997.
35.
Lombardi AV Jr, Berend KR, Mallory TH, Skeels MD, Adams JB. Survivorship of 2000 tapered titanium porous plasma-sprayed femoral components. Clin Orthop Relat Res. 2009;467:146–154.PubMedCrossRef
36.
Loughead JM, O’Connor PA, Charron K, Rorabeck CH, Bourne RB. Twenty-three-year outcome of the porous coated anatomic total hip replacement: a concise follow-up of a previous report. J Bone Joint Surg Am. 2012;94:151–155.PubMedCrossRef
37.
Martinez de Aragon JS, Keisu KS. 21-year results of the uncemented fully textured lord hip prosthesis. Clin Orthop Relat Res. 2007;454:133–138.PubMedCrossRef
38.
McLaughlin JR, Lee KR. Total hip arthroplasty with an uncemented tapered femoral component. J Bone Joint Surg Am. 2008;90:1290–1296.PubMedCrossRef
39.
McLaughlin JR, Lee KR. Uncemented total hip arthroplasty with a tapered femoral component: a 22- to 26-year follow-up study. Orthopedics. 2010;33:639.PubMed
40.
McLaughlin JR, Lee KR. Total hip arthroplasty with an uncemented tapered femoral component in patients younger than 50 years. J Arthroplasty. 2011;26:9–15.PubMedCrossRef
41.
Morshed S, Bozic KJ, Ries MD, Malchau H, Colford JM Jr. Comparison of cemented and uncemented fixation in total hip replacement: a meta-analysis. Acta Orthop. 2007;78:315–326.PubMedCrossRef
42.
Mueller LA, Wenger N, Schramm M, Hohmann D, Forst R, Carl HD. Seventeen-year survival of the cementless CLS Spotorno stem. Arch Orthop Trauma Surg. 2010;130:269–275.CrossRef
43.
Murray DW. Cemented femoral fixation: the North Atlantic divide. Orthopedics. 2011;34:e462–463.PubMed
44.
Nieuwenhuijse MJ, Valstar ER, Kaptein BL, Nelissen RG. Good diagnostic performance of early migration as a predictor of late aseptic loosening of acetabular cups: results from ten years of follow-up with Roentgen stereophotogrammetric analysis (RSA). J Bone Joint Surg Am. 2012;94:874–880.PubMedCrossRef
45.
Rozkydal Z, Janicek P, Havlicek V, Pazourek L. [Long-term results of use of the CLS stem in primary total hip arthroplasty] [in Czech]. Acta Chir Orthop Trauma Cesh. 2009;76:281–287.
46.
Saito S, Ishii T, Mori S, Hosaka K, Tokuhashi Y. The Harris-Galante cementless THA: a 19- to 25-year follow-up study. Orthopedics. 2011;34:12.PubMed
47.
Schramm M, Keck F, Hohmann D, Pitto RP. Total hip arthroplasty using an uncemented femoral component with taper design: outcome at 10-year follow-up. Arch Orthop Trauma Surg. 2000;120:407–412.PubMedCrossRef
48.
Siebold R, Scheller G, Schreiner U, Jani L. [Long-term results with the cement-free Spotorno CLS shaft] [in German]. Der Orthopade. 2001;30:317–322.PubMedCrossRef
49.
Spotorno L, Romagnoli S, Ivaldo N, Grappiolo G, Bibbiani E, Blaha DJ, Guen TA. The CLS system. Theoretical concept and results. Acta Orthop Belg. 1993;59(Suppl 1):144–148.PubMed
50.
Streit MR, Merle C, Clarius M, Aldinger PR. Late peri-prosthetic femoral fracture as a major mode of failure in uncemented primary hip replacement. J Bone Joint Surg Br. 2011;93:178–183.PubMedCrossRef
51.
Streit MR, Schroder K, Korber M, Merle C, Gotterbarm T, Ewerbeck V, Aldinger PR. High survival in young patients using a second generation uncemented total hip replacement. Int Orthop. 2012;36:1129–1136.PubMedCrossRef
52.
Taylor F, Wright M, Zhu M. Hemiarthroplasty of the hip with and without cement: a randomized clinical trial. J Bone Joint Surg Am. 2012;94:577–583.PubMedCrossRef
53.
Terre RA. Estimated survival probability of the Spotorno total hip arthroplasty after a 15- to 21-year follow-up: one surgeon’s results. Hip Int. 2010;20(Suppl 7):70–78.
54.
Metadata
Title
Long-term (20- to 25-year) Results of an Uncemented Tapered Titanium Femoral Component and Factors Affecting Survivorship
Authors
Marcus R. Streit, MD, MSc
Moritz M. Innmann, MD
Christian Merle, MD, MSc
Thomas Bruckner, PhD
Peter R. Aldinger, MD, PhD
Tobias Gotterbarm, MD
Publication date
01-10-2013
Publisher
Springer US
Published in
Clinical Orthopaedics and Related Research® / Issue 10/2013
Print ISSN: 0009-921X
Electronic ISSN: 1528-1132
DOI
https://doi.org/10.1007/s11999-013-3033-4

Other articles of this Issue 10/2013

Clinical Orthopaedics and Related Research® 10/2013 Go to the issue

Symposium: 2012 Musculoskeletal Infection Society

In Memoriam: George Cierny, III MD (1947–2013)

Orthopaedic Healthcare Worldwide

Collaborative Partnerships and the Future of Global Orthopaedics

Clinical Faceoff

Surgery for Degenerative Spondylolisthesis: Open Versus Minimally Invasive Surgery

Reply to the Letter to the Editor

Reply to the Letter to the Editor: Hip Resurfacing Does Not Improve Proprioception Compared With THA

Letter to the Editor

Letter to the Editor: Obesity Does Not Imply Poor Outcomes in Asians after Total Knee Arthroplasty

Letter to the Editor

Letter to the Editor: Hip Resurfacing Does Not Improve Proprioception Compared With THA